Cypress Capital Group raised its holdings in shares of Lam Research Co. (NASDAQ:LRCX - Free Report) by 622.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 26,450 shares of the semiconductor company's stock after buying an additional 22,790 shares during the quarter. Cypress Capital Group's holdings in Lam Research were worth $1,910,000 as of its most recent SEC filing.
Other large investors have also modified their holdings of the company. Financial Perspectives Inc grew its holdings in shares of Lam Research by 908.8% during the fourth quarter. Financial Perspectives Inc now owns 343 shares of the semiconductor company's stock worth $25,000 after buying an additional 309 shares in the last quarter. Atwood & Palmer Inc. purchased a new stake in shares of Lam Research in the fourth quarter valued at about $27,000. Midwest Capital Advisors LLC purchased a new stake in shares of Lam Research in the fourth quarter valued at about $27,000. West Oak Capital LLC grew its holdings in shares of Lam Research by 50.9% in the fourth quarter. West Oak Capital LLC now owns 400 shares of the semiconductor company's stock valued at $29,000 after purchasing an additional 135 shares during the period. Finally, Country Trust Bank grew its holdings in shares of Lam Research by 900.0% in the fourth quarter. Country Trust Bank now owns 400 shares of the semiconductor company's stock valued at $29,000 after purchasing an additional 360 shares during the period. Hedge funds and other institutional investors own 84.61% of the company's stock.
Analyst Ratings Changes
LRCX has been the subject of several research analyst reports. Mizuho increased their target price on shares of Lam Research from $87.00 to $100.00 and gave the stock an "outperform" rating in a research note on Thursday, February 20th. Sanford C. Bernstein raised shares of Lam Research from a "market perform" rating to an "outperform" rating and increased their target price for the stock from $85.00 to $91.00 in a research note on Thursday, January 30th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $100.00 target price on shares of Lam Research in a research note on Tuesday, February 18th. Morgan Stanley increased their price target on shares of Lam Research from $76.00 to $78.00 and gave the stock an "equal weight" rating in a research report on Thursday, December 5th. Finally, Susquehanna raised shares of Lam Research from a "neutral" rating to a "positive" rating and increased their price target for the stock from $75.00 to $125.00 in a research report on Thursday, February 20th. Six investment analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $98.22.
Read Our Latest Research Report on Lam Research
Insider Activity at Lam Research
In related news, SVP Seshasayee Varadarajan sold 110,080 shares of Lam Research stock in a transaction on Thursday, February 20th. The shares were sold at an average price of $90.00, for a total value of $9,907,200.00. Following the transaction, the senior vice president now directly owns 179,084 shares in the company, valued at $16,117,560. This trade represents a 38.07 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.29% of the stock is currently owned by insiders.
Lam Research Stock Up 3.4 %
LRCX stock traded up $2.61 during midday trading on Wednesday, reaching $79.05. 15,397,965 shares of the company were exchanged, compared to its average volume of 11,070,426. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.73 and a current ratio of 2.54. The company has a market cap of $101.47 billion, a price-to-earnings ratio of 24.01, a price-to-earnings-growth ratio of 1.47 and a beta of 1.46. The stock's 50-day simple moving average is $79.14 and its 200 day simple moving average is $77.82. Lam Research Co. has a 1-year low of $68.87 and a 1-year high of $113.00.
Lam Research (NASDAQ:LRCX - Get Free Report) last announced its earnings results on Wednesday, January 29th. The semiconductor company reported $0.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.87 by $0.04. Lam Research had a net margin of 26.49% and a return on equity of 51.86%. On average, equities analysts forecast that Lam Research Co. will post 3.71 earnings per share for the current year.
Lam Research Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 9th. Investors of record on Wednesday, March 5th will be given a $0.23 dividend. The ex-dividend date is Wednesday, March 5th. This represents a $0.92 dividend on an annualized basis and a yield of 1.16%. Lam Research's dividend payout ratio (DPR) is 27.96%.
About Lam Research
(
Free Report)
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Featured Stories

Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.